Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?

NCT ID NCT03034356

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This trial tests whether levetiracetam, a drug used for seizures, can reduce overactivity in the hippocampus—a brain area linked to memory—and improve cognitive function in people with schizophrenia or schizoaffective disorder. Participants receive either levetiracetam or a placebo, and researchers measure changes in brain activity using fMRI and assess thinking skills with a standard test. The goal is to see if calming this brain region can help with the memory and thinking problems that often accompany schizophrenia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
levetiracetam (an anti-seizure drug)
What this could lead to
If it works, levetiracetam could offer a new way to improve memory and thinking in people with schizophrenia.
What could go wrong
This is an early-stage trial with a small number of participants, so results may not hold up in larger studies. The drug may also cause side effects like dizziness or sleepiness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOAFFECTIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rocky Mountain Regional VA Medical Center, Aurora, CO

    Aurora, Colorado, 80045-7211, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.